Arvind Ponnusamy

987 total citations
32 papers, 356 citations indexed

About

Arvind Ponnusamy is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Arvind Ponnusamy has authored 32 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Arvind Ponnusamy's work include Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Arvind Ponnusamy is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Arvind Ponnusamy collaborates with scholars based in United Kingdom, Australia and United States. Arvind Ponnusamy's co-authors include Ching M. Cheung, Ann E. Canfield, Rebecca F. Taylor, Alexander Woywodt, Tobias E. Larsson, Karolina Lindberg, Risul Amin, Hannes Olauson, Karolina Kublickiene and Moosa Mohammadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and World Journal of Gastroenterology.

In The Last Decade

Arvind Ponnusamy

24 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arvind Ponnusamy United Kingdom	9	199	76	73	67	43	32	356
Sven‐Jean Tan Australia	12	298 1.5×	95 1.3×	64 0.9×	94 1.4×	51 1.2×	35	479
Shingo Okuno Japan	11	243 1.2×	61 0.8×	48 0.7×	71 1.1×	29 0.7×	27	450
Cengiz Candan Türkiye	12	211 1.1×	43 0.6×	53 0.7×	90 1.3×	34 0.8×	29	390
Hédi Ben Maïz Tunisia	10	137 0.7×	42 0.6×	55 0.8×	65 1.0×	17 0.4×	44	339
Ken‐ichi Samejima Japan	12	306 1.5×	77 1.0×	53 0.7×	67 1.0×	46 1.1×	42	509
Markus Pirklbauer Austria	15	135 0.7×	30 0.4×	79 1.1×	130 1.9×	41 1.0×	33	462
Killian Donovan United Kingdom	8	116 0.6×	45 0.6×	27 0.4×	57 0.9×	41 1.0×	10	349
Laura Florea Romania	11	124 0.6×	57 0.8×	34 0.5×	114 1.7×	40 0.9×	33	387
Cheryl P. Sanchez United States	15	329 1.7×	88 1.2×	94 1.3×	115 1.7×	95 2.2×	36	615
Taner Demirci Türkiye	13	83 0.4×	30 0.4×	26 0.4×	60 0.9×	84 2.0×	53	465

Countries citing papers authored by Arvind Ponnusamy

Since Specialization

Citations

This map shows the geographic impact of Arvind Ponnusamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Ponnusamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Ponnusamy more than expected).

Fields of papers citing papers by Arvind Ponnusamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Ponnusamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Ponnusamy. The network helps show where Arvind Ponnusamy may publish in the future.

Co-authorship network of co-authors of Arvind Ponnusamy

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Ponnusamy. A scholar is included among the top collaborators of Arvind Ponnusamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Ponnusamy. Arvind Ponnusamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Henry H. L., et al.. (2025). Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?. Antibodies. 14(1). 25–25. 1 indexed citations

Hengel, Felicitas E., Matthias Janneck, Henry H. L. Wu, et al.. (2025). Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy. Kidney International Reports. 10(8). 2800–2804.

Wu, Henry H. L., Amina Rakisheva, Arvind Ponnusamy, & Rajkumar Chinnadurai. (2024). Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?. World Journal of Gastroenterology. 30(2). 128–136. 8 indexed citations

Tollitt, James, Nikolaos Marketos, Ajay Dhaygude, et al.. (2024). IgA vasculitis nephritis—outcomes in adult-onset disease. Lara D. Veeken. 64(2). 690–696. 4 indexed citations

Wu, Henry H. L., et al.. (2024). Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy. Clinical Kidney Journal. 17(7). sfae189–sfae189.

Floyd, Lauren, Henry H. L. Wu, Rajkumar Chinnadurai, & Arvind Ponnusamy. (2023). Stenotrophomonas maltophilia: A Case Series and Review for an Uncommon Cause of Peritoneal Dialysis-Associated Infection. SHILAP Revista de lepidopterología. 3(1). 75–83.

Wu, Henry H. L., et al.. (2023). Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease. Clinical Kidney Journal. 17(1). sfad270–sfad270.

Wu, Henry H. L., et al.. (2023). COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?. Vaccines. 11(7). 1139–1139. 3 indexed citations

Floyd, Lauren, Adam Morris, Henry H. L. Wu, et al.. (2023). #4146 LIMITATIONS AND UNCERTAINTIES OF ASSESSING AND MANAGING OLDER PATIENTS WITH ANCA ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 38(Supplement_1).

10.

Wu, Henry H. L., et al.. (2022). Pruritus in Chronic Kidney Disease: An Update. SHILAP Revista de lepidopterología. 2(3). 87–105. 7 indexed citations

11.

Wu, Henry H. L., et al.. (2022). Concurrent presentation of IgG4-related tubulointerstitial nephritis and ANCA MPO crescentic glomerulonephritis. PubMed. 10(1). 47–53. 4 indexed citations

12.

Newton, Joseph, et al.. (2021). Thrombotic microangiopathy secondary to recurrent prostate cancer. PubMed. 9(1). 105–109.

13.

Storrar, Joshua, Henry H. L. Wu, Arvind Ponnusamy, et al.. (2021). Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World Journal of Transplantation. 11(11). 480–502. 8 indexed citations

14.

Al‐Chalabi, Saif, Henry H. L. Wu, Rajkumar Chinnadurai, & Arvind Ponnusamy. (2021). Etanercept-Induced Anti-Glomerular Basement Membrane Disease. Case Reports in Nephrology and Dialysis. 11(3). 292–300. 2 indexed citations

15.

Dhaygude, Ajay, et al.. (2021). Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patients. Clinical Kidney Journal. 15(5). 903–911. 10 indexed citations

16.

Morris, Adam, Mohamed Elsayed, Arvind Ponnusamy, et al.. (2020). Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis. American Journal of Nephrology. 51(4). 327–336. 11 indexed citations

17.

Ali, Hatem, et al.. (2020). The outcome of kidney transplant from living donors with pelvi-ureteric junction dysfunction. International Urology and Nephrology. 52(10). 1863–1868.

18.

Hamilton, Patrick, Rajkumar Chinnadurai, Smeeta Sinha, et al.. (2019). The investigative burden of membranous nephropathy in the UK. Clinical Kidney Journal. 13(1). 27–34. 8 indexed citations

19.

Ponnusamy, Arvind, Smeeta Sinha, Gareth Hyde, et al.. (2018). FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis. PLoS ONE. 13(4). e0196232–e0196232. 38 indexed citations

20.

Lindberg, Karolina, Hannes Olauson, Risul Amin, et al.. (2013). Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function. PLoS ONE. 8(4). e60658–e60658. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact